Limited Efficacy of Intensified Preparative Regimens and Autologous Transplantation as Salvage Therapy in High Grade Non-Hodgkin's Lymphoma

References

• Phillips G. L., Herzig R. H., Lazarus H. M., Fay J. W., Wolff S. N., Mill W. B., Lin H., Thomas P. R. M., Glasgow G. P., Shina D. C., Herzig G. P. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous bone marrow. N Engl J Med 1984; 310: 1557–1561
   PubMed Web of Science ®Google Scholar
• Philip T., Armitage J. O., Spitzer G., Chauvin R., Jagannath S., Cahn J., Colombat P., Goldstone A. H., Gorin N. C., Flesh M., Laporte J., Maraninchi D., Pico J., Bosly A., Anderson C., Schots R., Biron P., Cabanillas F., Dicke K. High dose therapy and autologous marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493–1498
   PubMed Web of Science ®Google Scholar
• Takvorian T., Canellos G. P., Ritz J., Freedman A. S., Anderson K. C., Mauch P., Tarbell N., Coral F., Daley H., Yeap B., Schlossman S. F., Nadler L. M. Prolonged disease free survival after autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 1987; 316: 1499–1505
   PubMed Web of Science ®Google Scholar
• Armitage J. O. Bone marrow transplantation in the treatment of patients with lymphoma. Blood 1989; 73: 1749–1758
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Nadler L. M. Which patients with relapsed non-Hodgkin's lymphoma benefit from high dose therapy and hematopoietic stem cell transplantation? (Editorial). J Clin Oncol 1993; 11: 1841–1843
   PubMed Web of Science ®Google Scholar
• Stein R. S., Greer J. P., Goodman S., Brandt S. J., Morgan D. S., Macon W. R., McCurley T. L., Wolff S. N. Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma. Bone Marrow Transplantation 2000; 25: 257–262
   PubMed Web of Science ®Google Scholar
• Velasquez W. S., Cabanillas R., Salvador P., McLaughlin P., Fridrik M., Tucker S., Jagganath S., Hagemeister F. B., Redman J. R., Swan F. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ARA-C and dexamethasone (DHAP). Blood 1988; 71: 117–122
   PubMed Web of Science ®Google Scholar
• Velasquez W. S., McLaughlin P., Tucker S., Hagemeister F. B., Swan F., Rodriguez M. A., Romaguera J., Rubenstein E., Cabanillas F. ESHAP—An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study. J Clin Oncol 1994; 12: 1169–1176
   PubMed Web of Science ®Google Scholar
• Kaplan E. L., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Philip T., Guglielmi C., Hagenbeek A., Somers R., Van Der Lelie H., Bron D., Sonneveld P., Gisselbrecht C., Cahn J., Harousseau J., Coiffier B., Biron P., Mandelli F., Chauvin F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540–1545
   PubMed Web of Science ®Google Scholar
• McMaster M. L., Greer J. P., Greco F. A., Johnson D. H., Wolff S. N., Hainsworth J. D. Effective treatment of small non-cleaved cell lymphoma with high intensity, brief duration chemotherapy. J Clin Oncol 1991; 9: 941–946
   PubMed Web of Science ®Google Scholar
• Magrath I., Adde M., Shad A., Venzon D., Seibel N., Gootenberg J., Neely J., Arndt C., Nieder M., Jaffe E., Wittes R. A., Horak I. D. Adults and children with small non-cleaved cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996; 14: 925–934
   PubMed Web of Science ®Google Scholar
• Stiff P. J., Dahlberg S., Forman S. J., McCall A. R., Horning S. J., Nademanee A. P., Blume K. G., LeBlanc M., Fisher R. I. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens—A Southwest Oncology Group Study. J Clin Oncol 1998; 16: 48–55
   PubMed Web of Science ®Google Scholar
• Sweetenham J. W., Pearce R., Taghipour G., Blaise D., Gisselbrecht C., Goldstone A. H. Adult Burkitt's and Burkitt's-like Non-Hodgkin's lymphoma—outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European group for blood and bone marrow transplantation. J Clin Oncol 1996; 14: 2465–2472, for the European Group for Blood and Marrow Transplantation Lymphoma Working Party
   PubMed Web of Science ®Google Scholar
• Haioun C., Lepage E., Gisselbrecht C., Coiffier B., Bosly A., Tilly H., Morel P., Nouvel C., Herbrecht R., D'Agay M. F., Gaulard P., Reyes F. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate grade and high grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients. J Clin Oncol 1994; 12: 2543–2551, for the Group d'Etude des Lymphomes de l'Adulte
   PubMed Web of Science ®Google Scholar
• Haioun C., Lepage E., Gisselbrecht C., Bastion Y., Coiffier B., Brice P., Bosly A., Dupriez B., Nouvel C., Tilly H., Lederlin P., Biron P., Briere J., Gaulard P., Reyes P. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87–2. J Clin Oncol 1997; 15: 1131–1137, for the Group d'Etude des Lymphomes de l'Adulte
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive clinical model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar